StoneX Group Portfolio holdings
StoneX Group is a financial services firm that has six lines of business: foreign exchange, securities, physical commodities, global payments, commercial hedging, and clearing and execution services. It was known as INTL FCStone until 2020, a name chosen in 2011 after International Assets Holding Corporation merged with FCStone Group. In 2019 it launched a prime brokerage division that clears trades for hedge funds, mutual funds and family offices. In 2020 StoneX agreed to buy GAIN Capital, the operator of the Forex.com and City Index retail trading brands.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Semiconductor ETF
SOXX
|
+$27.9M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$21.3M |
| 3 |
iShares MSCI ACWI ETF
ACWI
|
+$14.4M |
| 4 |
Micron Technology
MU
|
+$14.2M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$8.54M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KT
KT
|
+$25.8M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$16.1M |
| 3 |
Xcel Energy
XEL
|
+$13.3M |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$11.2M |
| 5 |
Direxion Daily Semiconductor Bull 3X ETF
SOXL
|
+$9.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 69.27% |
| 2 | Technology | 9.13% |
| 3 | Financials | 7.69% |
| 4 | Industrials | 2.87% |
| 5 | Healthcare | 2.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1801
Autozi Internet Technology
AZI
$48.1M
| $14K | ﹤0.01% |
+11,642
| New | +$15.4K |
2026 Q3
0 quarters
|
|
1802
Bioceres Crop Solutions
BIOX
$16.2M
| $13.9K | ﹤0.01% |
+34,104
| New | +$12.9K |
2026 Q3
0 quarters
|
|
1803
Aldeyra Therapeutics
ALDX
$39.1M
| $13.9K | ﹤0.01% |
10,367
-8,929
| -46% | -$14.3K |
2026 Q2
1 quarter
|
|
1804
Arrive AI Inc
ARAI
$7.15M
| $13.8K | ﹤0.01% |
59,770
+35,442
| +146% | +$9.8K |
2026 Q2
1 quarter
|
|
1805
China Pharma Holdings
CPHI
$25.3M
| $13.6K | ﹤0.01% |
+16,304
| New | +$17.2K |
2026 Q3
0 quarters
|
|
1806
Gevo
GEVO
$316M
| $13.6K | ﹤0.01% |
+10,229
| New | +$15.9K |
2026 Q3
0 quarters
|
|
1807
GeoVax Labs
GOVX
$1.53M
| $13.6K | ﹤0.01% |
+21,145
| New | +$14.8K |
2026 Q3
0 quarters
|
|
1808
Calidi Biotherapeutics
CLDI
$1.89M
| $13.4K | ﹤0.01% |
+11,311
| New | +$17.6K |
2026 Q3
0 quarters
|
|
1809
Worksport
WKSP
$6.01M
| $13.3K | ﹤0.01% |
22,897
+5,506
| +32% | +$3.43K |
2026 Q2
1 quarter
|
|
1810
Parabolic Technologies, Inc. Class A Common Stock
PARA
$166K
| $13.2K | ﹤0.01% |
+1,120
| New | +$18.5K |
2026 Q3
0 quarters
|
|
1811
Turbo Energy
TURB
$10.9M
| $13.1K | ﹤0.01% |
+11,093
| New | +$14.4K |
2026 Q3
0 quarters
|
|
1812
Compass Therapeutics
CMPX
$137M
| $13.1K | ﹤0.01% |
10,142
-4,858
| -32% | -$10K |
2026 Q2
1 quarter
|
|
1813
AgEagle Aerial Systems
UAVS
$21.8M
| $12.8K | ﹤0.01% |
18,404
-1,702
| -8% | -$1.54K |
2026 Q2
1 quarter
|
|
1814
EON Resources
EONR
$15.4M
| $12.8K | ﹤0.01% |
+24,664
| New | +$12.8K |
2026 Q3
0 quarters
|
|
1815
Organigram Holdings
OGI
$139M
| $12.8K | ﹤0.01% |
13,128
-4,502
| -26% | -$4.81K |
2025 Q4
3 quarters
|
|
1816
Connect Biopharma Holdings
CNTB
$49.2M
| $12.6K | ﹤0.01% |
+11,479
| New | +$23.4K |
2026 Q3
0 quarters
|
|
1817
Newbury Street II Acquisition Corp Warrant
NTWOW
$7.33M
| $12.5K | ﹤0.01% |
+10,691
| New | +$9.8K |
2026 Q3
0 quarters
|
|
1818
Investcorp Credit Management BDC
ICMB
$9.5M
| $12.4K | ﹤0.01% |
+15,218
| New | +$12.9K |
2026 Q3
0 quarters
|
|
1819
Azitra
AZTR
$4.94M
| $12.4K | ﹤0.01% |
8,467
+5,602
| +196% | +$8.45K |
2026 Q1
2 quarters
|
|
1820
Rocky Mountain Chocolate Factory
RMCF
$7.94M
| $12.4K | ﹤0.01% |
+12,502
| New | +$12.4K |
2026 Q3
0 quarters
|
|
1821
Citius Oncology
CTOR
$57.9M
| $12.3K | ﹤0.01% |
+13,719
| New | +$10.7K |
2026 Q3
0 quarters
|
|
1822
PharmaCyte Biotech
PMCB
$4.09M
| $12.3K | ﹤0.01% |
+30,006
| New | +$16.5K |
2026 Q3
0 quarters
|
|
1823
Fusemachines Inc
FUSE
$11.4M
| $12.3K | ﹤0.01% |
+20,899
| New | +$16.5K |
2026 Q3
0 quarters
|
|
1824
Netcapital
NCPL
$11.3M
| $12.1K | ﹤0.01% |
+11,031
| New | +$6.01K |
2026 Q3
0 quarters
|
|
1825
Onconetix
ONCO
$3.88M
| $12.1K | ﹤0.01% |
+15,409
| New | +$12.6K |
2026 Q3
0 quarters
|
|
Similar funds
StoneX Group's Q3 2026 Portfolio in Review
As of Q3 2026, StoneX Group held 2,403 positions worth $2.75B, up 11% from $2.48B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
StoneX Group deployed $299M of net new capital in Q3 2026, opening 939 new positions and adding to 616 existing holdings. Its largest new stake was iShares MSCI ACWI ETF: 90,830 shares worth $14.4M.
By sector, the portfolio is most concentrated in Miscellaneous at 69% of assets, down from 70% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $16.1M trimmed.
- StoneX Group's largest Q3 2026 buy was iShares MSCI ACWI ETF: 90,830 shares worth $14.4M.
- StoneX Group added most to iShares Semiconductor ETF in Q3 2026, an estimated $27.9M increase.
- StoneX Group's biggest Q3 2026 reduction was Vanguard S&P 500 ETF, cutting an estimated $16.1M.
- StoneX Group fully exited KT in Q3 2026, selling an estimated $25.8M.
- StoneX Group's ten largest holdings make up 25% of its $2.75B portfolio in Q3 2026.
- StoneX Group opened 939 new positions and closed 465 in Q3 2026.
- StoneX Group's portfolio value rose 11% quarter-over-quarter to $2.75B.
Based on StoneX Group's 13F filing for Q3 2026, filed 3 Nov 2026.